Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add filters

Database
Language
Document Type
Year range
1.
Natl Sci Rev ; 9(4): nwab223, 2022 Apr.
Article in English | MEDLINE | ID: covidwho-1821756

ABSTRACT

In the spread of SARS-CoV-2, there have been multiple waves of replacement between strains, each of which having a distinct set of mutations. The first wave is a group of four mutations (C241T, C3037T, C14408T and A23403G [this being the amino acid change D614G]; all designated 0 to 1 below). This DG (D614G) group, fixed at the start of the pandemic, is the foundation of all subsequent waves of strains. Curiously, the DG group is absent in early Asian samples but present (and likely common) in Europe from the beginning. European data show that the high fitness of DG1111 requires the synergistic effect of all four mutations. However, the European strains would have had no time to evolve the four DG mutations (0 to 1), had they come directly from the early Asian DG0000 strain. Very likely, the European DG1111 strain had acquired the highly adaptive DG mutations in pre-pandemic Europe and had been spreading in parallel with the Asian strains. Two recent reports further support this twin-beginning interpretation. There was a period of two-way spread between Asia and Europe but, by May 2020, the European strains had supplanted the Asian strains globally. This large-scale replacement of one set of mutations for another has since been replayed many times as COVID-19 progresses.

3.
Mol Biol Evol ; 39(3)2022 03 02.
Article in English | MEDLINE | ID: covidwho-1722547

ABSTRACT

In new epidemics after the host shift, the pathogens may experience accelerated evolution driven by novel selective pressures. When the accelerated evolution enters a positive feedback loop with the expanding epidemics, the pathogen's runaway evolution may be triggered. To test this possibility in coronavirus disease 2019 (COVID-19), we analyze the extensive databases and identify five major waves of strains, one replacing the previous one in 2020-2021. The mutations differ entirely between waves and the number of mutations continues to increase, from 3-4 to 21-31. The latest wave in the fall of 2021 is the Delta strain which accrues 31 new mutations to become highly prevalent. Interestingly, these new mutations in Delta strain emerge in multiple stages with each stage driven by 6-12 coding mutations that form a fitness group. In short, the evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from the oldest to the youngest wave, and from the earlier to the later stages of the Delta wave, is a process of acceleration with more and more mutations. The global increase in the viral population size (M(t), at time t) and the mutation accumulation (R(t)) may have indeed triggered the runaway evolution in late 2020, leading to the highly evolved Alpha and then Delta strain. To suppress the pandemic, it is crucial to break the positive feedback loop between M(t) and R(t), neither of which has yet to be effectively dampened by late 2021. New waves after Delta, hence, should not be surprising.


Subject(s)
COVID-19 , SARS-CoV-2 , COVID-19/genetics , Humans , Mutation , Pandemics , SARS-CoV-2/genetics
6.
Sci Bull (Beijing) ; 66(10): 1022-1029, 2021 May 30.
Article in English | MEDLINE | ID: covidwho-1059386

ABSTRACT

A virus that can cause a global pandemic must be highly adaptive to human conditions. Such adaptation is not likely to have emerged suddenly but, instead, may have evolved step by step with each step favored by natural selection. It is thus necessary to develop a theory about the origin in order to guide the search. Here, we propose such a model whereby evolution occurs in both the virus and the hosts (where the evolution is somatic; i.e., in the immune system). The hosts comprise three groups - the wild animal hosts, the nearby human population, and farther-away human populations. The theory suggests that the conditions under which the pandemic has initially evolved are: (i) an abundance of wild animals in the place of origin (PL0); (ii) a nearby human population of low density; (iii) frequent and long-term animal-human contacts to permit step-by-step evolution; and (iv) a level of herd immunity in the animal and human hosts. In this model, the evolving virus may have regularly spread out of PL0 although such invasions often fail, leaving sporadic cases of early infections. The place of the first epidemic (PL1), where humans are immunologically naïve to the virus, is likely a distance away from PL0. Finally, this current model is only a first attempt and more theoretical models can be expected to guide the search for the origin of SARS-CoV-2.

7.
Natl Sci Rev ; 7(2): 237-238, 2020 Feb.
Article in English | MEDLINE | ID: covidwho-882219
8.
Natl Sci Rev ; 8(1): nwaa246, 2021 Jan.
Article in English | MEDLINE | ID: covidwho-793335

ABSTRACT

How many incoming travelers (I0 at time 0, equivalent to the 'founders' in evolutionary genetics) infected with SARS-CoV-2 who visit or return to a region could have started the epidemic of that region? I0 would be informative about the initiation and progression of epidemics. To obtain I0 , we analyze the genetic divergence among viral populations of different regions. By applying the 'individual-output' model of genetic drift to the SARS-CoV-2 diversities, we obtain I0 < 10, which could have been achieved by one infected traveler in a long-distance flight. The conclusion is robust regardless of the source population, the continuation of inputs (It for t > 0) or the fitness of the variants. With such a tiny trickle of human movement igniting many outbreaks, the crucial stage of repressing an epidemic in any region should, therefore, be the very first sign of local contagion when positive cases first become identifiable. The implications of the highly 'portable' epidemics, including their early evolution prior to any outbreak, are explored in the companion study (Ruan et al., personal communication).

9.
Natl Sci Rev ; 7(4): 719-720, 2020 Apr.
Article in English | MEDLINE | ID: covidwho-1185
SELECTION OF CITATIONS
SEARCH DETAIL